MAIN MENU
|
Our Home Page
|
The Human Need
|
Senior Staff Vacancy
|
Haemair in Public
|
Investment Finance
|
Company Directors
|
Collaborators
|
Contact Us
|
Development Plan
|
The Haemair Device
|
Senior Staff
|
|
Associated Companies
|
|
|
|
Finance and Investment Opportunuities
The share tranche for £300,000 announced last year was oversubscribed and we now have the funds that we planned to take us to the next stage of development.
We appreciate that we were not able to issue shares to a few potential investors within the timetable set. We will be issuing an additional smaller tranche to meet that unmet demand, but have not yet decided the number of shares or the timetable. We will allow sufficient time to ensure that such potential investors are fully aware of what we are doing and of the risks in investing in small high-tech companies.
In reaching our current position, we acknowledge support from a number of major investors including:
"Haemair Limited has a mission to reduce Acute deaths, improve the lives of
Chronic sufferers and to provide an alternative to lung transplantation."
|
